Study Assessing SEP-363856 in Male and Female Volunteers With High or Low Schizotype Characteristics

NCT01972711 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

105

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: SEP-363856
DRUG: Amisulpride
DRUG: Placebo

Sponsor

Otsuka Pharmaceutical Development & Commercialization, Inc.